{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:08:15Z","timestamp":1780438095127,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":152,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05925-6","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:58:54Z","timestamp":1780437534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gain-of-function Modulation of TREM2 and its Impact on Amyloid-\u03b2 and Tau Pathologies in Alzheimer\u2019s Disease: A Systematic Review and Meta-analysis of Animal Studies"],"prefix":"10.1007","volume":"63","author":[{"given":"Yingdi","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianna","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luoqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"5","key":"5925_CR1","doi-asserted-by":"publisher","first-page":"ITC33","DOI":"10.7326\/AITC201909030","volume":"171","author":"ES Oh","year":"2019","unstructured":"Oh ES, Rabins PV (2019) Dementia. Ann Intern Med 171(5):ITC33\u2013ITC48. https:\/\/doi.org\/10.7326\/AITC201909030","journal-title":"Ann Intern Med"},{"issue":"2","key":"5925_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrn2967","volume":"12","author":"LM Ittner","year":"2011","unstructured":"Ittner LM, G\u00f6tz J (2011) Amyloid-\u03b2 and tau\u2013a toxic pas de deux in Alzheimer\u2019s disease. Nat Rev Neurosci 12(2):65\u201372. https:\/\/doi.org\/10.1038\/nrn2967","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"5925_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM (2019) Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179(2):312\u2013339. https:\/\/doi.org\/10.1016\/j.cell.2019.09.001","journal-title":"Cell"},{"issue":"13","key":"5925_CR4","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1523\/JNEUROSCI.5572-08.2009","volume":"29","author":"S Mandrekar","year":"2009","unstructured":"Mandrekar S, Jiang Q, Lee CY, Koenigsknecht-Talboo J, Holtzman DM, Landreth GE (2009) Microglia mediate the clearance of soluble A\u03b2 through fluid phase macropinocytosis. J Neurosci 29(13):4252\u20134262. https:\/\/doi.org\/10.1523\/JNEUROSCI.5572-08.2009","journal-title":"J Neurosci"},{"issue":"7","key":"5925_CR5","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B, Itzkovitz S, Colonna M, Schwartz M, Amit I (2017) A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169(7):1276-1290.e17. https:\/\/doi.org\/10.1016\/j.cell.2017.05.018","journal-title":"Cell"},{"issue":"6","key":"5925_CR6","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cell.2020.05.003","volume":"181","author":"A Deczkowska","year":"2020","unstructured":"Deczkowska A, Weiner A, Amit I (2020) The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway. Cell 181(6):1207\u20131217. https:\/\/doi.org\/10.1016\/j.cell.2020.05.003","journal-title":"Cell"},{"issue":"1","key":"5925_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-018-0298-9","volume":"13","author":"M Gratuze","year":"2018","unstructured":"Gratuze M, Leyns CEG, Holtzman DM (2018) New insights into the role of TREM2 in Alzheimer\u2019s disease. Mol Neurodegener 13(1):66. https:\/\/doi.org\/10.1186\/s13024-018-0298-9","journal-title":"Mol Neurodegener"},{"issue":"4","key":"5925_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrn.2016.7","volume":"17","author":"M Colonna","year":"2016","unstructured":"Colonna M, Wang Y (2016) TREM2 variants: new keys to decipher Alzheimer disease pathogenesis. Nat Rev Neurosci 17(4):201\u2013207. https:\/\/doi.org\/10.1038\/nrn.2016.7","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"5925_CR9","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41593-019-0433-0","volume":"22","author":"CEG Leyns","year":"2019","unstructured":"Leyns CEG, Gratuze M, Narasimhan S, Jain N, Koscal LJ, Jiang H, Manis M, Colonna M et al (2019) TREM2 function impedes tau seeding in neuritic plaques. Nat Neurosci 22(8):1217\u20131222. https:\/\/doi.org\/10.1038\/s41593-019-0433-0","journal-title":"Nat Neurosci"},{"issue":"12","key":"5925_CR10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20212479","volume":"219","author":"N Zhao","year":"2022","unstructured":"Zhao N, Qiao W, Li F, Ren Y, Zheng J, Martens YA, Wang X, Li L et al (2022) Elevating microglia TREM2 reduces amyloid seeding and suppresses disease-associated microglia. J Exp Med 219(12):e20212479. https:\/\/doi.org\/10.1084\/jem.20212479","journal-title":"J Exp Med"},{"issue":"9","key":"5925_CR11","doi-asserted-by":"publisher","first-page":"4954","DOI":"10.1172\/JCI138179","volume":"130","author":"M Gratuze","year":"2020","unstructured":"Gratuze M, Leyns CE, Sauerbeck AD, St-Pierre MK, Xiong M, Kim N, Serrano JR, Tremblay M\u00c8 et al (2020) Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration. J Clin Invest 130(9):4954\u20134968. https:\/\/doi.org\/10.1172\/JCI138179","journal-title":"J Clin Invest"},{"issue":"8","key":"5925_CR12","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.neuron.2021.02.010","volume":"109","author":"SH Lee","year":"2021","unstructured":"Lee SH, Meilandt WJ, Xie L, Gandham VD, Ngu H, Barck KH, Rezzonico MG, Imperio J et al (2021) Trem2 restrains the enhancement of tau accumulation and neurodegeneration by \u03b2-amyloid pathology. Neuron 109(8):1283-1301.e6. https:\/\/doi.org\/10.1016\/j.neuron.2021.02.010","journal-title":"Neuron"},{"issue":"13","key":"5925_CR13","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1038\/npp.2014.164","volume":"39","author":"T Jiang","year":"2014","unstructured":"Jiang T, Tan L, Zhu XC, Zhang QQ, Cao L, Tan MS, Gu LZ, Wang HF et al (2014) Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer\u2019s disease. Neuropsychopharmacology 39(13):2949\u20132962. https:\/\/doi.org\/10.1038\/npp.2014.164","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"5925_CR14","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.neuron.2018.02.002","volume":"97","author":"CYD Lee","year":"2018","unstructured":"Lee CYD, Daggett A, Gu X, Jiang LL, Langfelder P, Li X, Wang N, Zhao Y et al (2018) Elevated TREM2 gene dosage reprograms microglia responsivity and ameliorates pathological phenotypes in Alzheimer\u2019s disease models. Neuron 97(5):1032-1048.e5. https:\/\/doi.org\/10.1016\/j.neuron.2018.02.002","journal-title":"Neuron"},{"issue":"11","key":"5925_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cells12111549","volume":"12","author":"M Fassler","year":"2023","unstructured":"Fassler M, Benaim C, George J (2023) TREM2 agonism with a monoclonal antibody attenuates tau pathology and neurodegeneration. Cells 12(11):1549. https:\/\/doi.org\/10.3390\/cells12111549","journal-title":"Cells"},{"issue":"1","key":"5925_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13195-024-01599-1","volume":"16","author":"H Long","year":"2024","unstructured":"Long H, Simmons A, Mayorga A, Burgess B, Nguyen T, Budda B, Rychkova A, Rhinn H et al (2024) Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer\u2019s disease. Alzheimers Res Ther 16(1):235. https:\/\/doi.org\/10.1186\/s13195-024-01599-1","journal-title":"Alzheimers Res Ther"},{"issue":"9","key":"5925_CR17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200785","volume":"217","author":"S Wang","year":"2020","unstructured":"Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H, Ward M, Siddiqui O et al (2020) Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model. J Exp Med 217(9):e20200785. https:\/\/doi.org\/10.1084\/jem.20200785","journal-title":"J Exp Med"},{"issue":"1","key":"5925_CR18","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220654","volume":"220","author":"N Jain","year":"2023","unstructured":"Jain N, Lewis CA, Ulrich JD, Holtzman DM (2023) Chronic TREM2 activation exacerbates A\u03b2-associated tau seeding and spreading. J Exp Med 220(1):e20220654. https:\/\/doi.org\/10.1084\/jem.20220654","journal-title":"J Exp Med"},{"key":"5925_CR19","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, Clarke M, Devereaux PJ et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clinical research ed) 339:b2700. https:\/\/doi.org\/10.1136\/bmj.b2700","journal-title":"BMJ (Clinical research ed)"},{"issue":"9","key":"5925_CR20","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1039\/d1fo03958j","volume":"13","author":"T Hu","year":"2022","unstructured":"Hu T, Yue J, Tang Q, Cheng KW, Chen F, Peng M, Zhou Q, Wang M (2022) The effect of quercetin on diabetic nephropathy (DN): a systematic review and meta-analysis of animal studies. Food Funct 13(9):4789\u20134803. https:\/\/doi.org\/10.1039\/d1fo03958j","journal-title":"Food Funct"},{"key":"5925_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW (2014) SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol 14:43. https:\/\/doi.org\/10.1186\/1471-2288-14-43","journal-title":"BMC Med Res Methodol"},{"issue":"29","key":"5925_CR22","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2347-23.2024","volume":"44","author":"A Etxeberria","year":"2024","unstructured":"Etxeberria A, Shen YA, Vito S, Silverman SM, Imperio J, Lalehzadeh G, Soung AL, Du C et al (2024) Neutral or detrimental effects of TREM2 agonist antibodies in preclinical models of Alzheimer\u2019s disease and multiple sclerosis. J Neurosci 44(29):e2347232024. https:\/\/doi.org\/10.1523\/JNEUROSCI.2347-23.2024","journal-title":"J Neurosci"},{"issue":"1","key":"5925_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01980-5","volume":"18","author":"M Fassler","year":"2021","unstructured":"Fassler M, Rappaport MS, Cu\u00f1o CB, George J (2021) Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in Alzheimer\u2019s disease models. J Neuroinflammation 18(1):19. https:\/\/doi.org\/10.1186\/s12974-020-01980-5","journal-title":"J Neuroinflammation"},{"issue":"2","key":"5925_CR24","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s12035-016-9704-x","volume":"54","author":"T Jiang","year":"2017","unstructured":"Jiang T, Wan Y, Zhang YD, Zhou JS, Gao Q, Zhu XC, Shi JQ, Lu H et al (2017) TREM2 overexpression has no improvement on neuropathology and cognitive impairment in aging APPswe\/PS1dE9 mice. Mol Neurobiol 54(2):855\u2013865. https:\/\/doi.org\/10.1007\/s12035-016-9704-x","journal-title":"Mol Neurobiol"},{"issue":"5","key":"5925_CR25","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1007\/s12035-023-03217-x","volume":"60","author":"X Peng","year":"2023","unstructured":"Peng X, Guo H, Zhang X, Yang Z, Ruganzu JB, Yang Z, Wu X, Bi W et al (2023) TREM2 inhibits tau hyperphosphorylation and neuronal apoptosis via the PI3K\/Akt\/GSK-3\u03b2 signaling pathway in vivo and in vitro. Mol Neurobiol 60(5):2470\u20132485. https:\/\/doi.org\/10.1007\/s12035-023-03217-x","journal-title":"Mol Neurobiol"},{"issue":"1","key":"5925_CR26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12974-020-01915-0","volume":"17","author":"BR Price","year":"2020","unstructured":"Price BR, Sudduth TL, Weekman EM, Johnson S, Hawthorne D, Woolums A, Wilcock DM (2020) Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition. J Neuroinflammation 17(1):238. https:\/\/doi.org\/10.1186\/s12974-020-01915-0","journal-title":"J Neuroinflammation"},{"key":"5925_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113506","volume":"336","author":"JB Ruganzu","year":"2021","unstructured":"Ruganzu JB, Zheng Q, Wu X, He Y, Peng X, Jin H, Zhou J, Ma R et al (2021) TREM2 overexpression rescues cognitive deficits in APP\/PS1 transgenic mice by reducing neuroinflammation via the JAK\/STAT\/SOCS signaling pathway. Exp Neurol 336:113506. https:\/\/doi.org\/10.1016\/j.expneurol.2020.113506","journal-title":"Exp Neurol"},{"issue":"4","key":"5925_CR28","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911227","volume":"12","author":"K Schlepckow","year":"2020","unstructured":"Schlepckow K, Monroe KM, Kleinberger G, Cantuti-Castelvetri L, Parhizkar S, Xia D, Willem M, Werner G et al (2020) Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region. EMBO Mol Med 12(4):e11227. https:\/\/doi.org\/10.15252\/emmm.201911227","journal-title":"EMBO Mol Med"},{"issue":"661","key":"5925_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq0095","volume":"14","author":"P Zhao","year":"2022","unstructured":"Zhao P, Xu Y, Jiang L, Fan X, Li L, Li X, Arase H, Zhao Y et al (2022) A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer\u2019s disease. Sci Transl Med 14(661):eabq0095. https:\/\/doi.org\/10.1126\/scitranslmed.abq0095","journal-title":"Sci Transl Med"},{"issue":"1","key":"5925_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12974-025-03420-8","volume":"22","author":"K Chen","year":"2025","unstructured":"Chen K, Li F, Zhang S, Chen Y, Ikezu TC, Li Z, Martens YA, Qiao W et al (2025) Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration. J Neuroinflammation 22(1):93. https:\/\/doi.org\/10.1186\/s12974-025-03420-8","journal-title":"J Neuroinflammation"},{"key":"5925_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115218","volume":"165","author":"Y Li","year":"2023","unstructured":"Li Y, Xu H, Wang H, Yang K, Luan J, Wang S (2023) TREM2: Potential therapeutic targeting of microglia for Alzheimer\u2019s disease. Biomed Pharmacother 165:115218. https:\/\/doi.org\/10.1016\/j.biopha.2023.115218","journal-title":"Biomed Pharmacother"},{"issue":"22","key":"5925_CR32","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1016\/j.cell.2022.09.033","volume":"185","author":"S Wang","year":"2022","unstructured":"Wang S, Sudan R, Peng V, Zhou Y, Du S, Yuede CM, Lei T, Hou J et al (2022) TREM2 drives microglia response to amyloid-\u03b2 via SYK-dependent and -independent pathways. Cell 185(22):4153-4169.e19. https:\/\/doi.org\/10.1016\/j.cell.2022.09.033","journal-title":"Cell"},{"issue":"10","key":"5925_CR33","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.jalz.2014.10.013","volume":"11","author":"P Roussos","year":"2015","unstructured":"Roussos P, Katsel P, Fam P, Tan W, Purohit DP, Haroutunian V (2015) The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer\u2019s dementia. Alzheimers Dement 11(10):1163\u20131170. https:\/\/doi.org\/10.1016\/j.jalz.2014.10.013","journal-title":"Alzheimers Dement"},{"key":"5925_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-9-20","volume":"9","author":"JD Ulrich","year":"2014","unstructured":"Ulrich JD, Finn MB, Wang Y, Shen A, Mahan TE, Jiang H, Stewart FR, Piccio L et al (2014) Altered microglial response to A\u03b2 plaques in APPPS1-21 mice heterozygous for TREM2. Mol Neurodegener 9:20. https:\/\/doi.org\/10.1186\/1750-1326-9-20","journal-title":"Mol Neurodegener"},{"issue":"9","key":"5925_CR35","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1523\/JNEUROSCI.1871-19.2019","volume":"40","author":"WJ Meilandt","year":"2020","unstructured":"Meilandt WJ, Ngu H, Gogineni A, Lalehzadeh G, Lee SH, Srinivasan K, Imperio J, Wu T et al (2020) Trem2 deletion reduces late-stage amyloid plaque accumulation, elevates the A\u03b242:A\u03b240 ratio, and exacerbates axonal dystrophy and dendritic spine loss in the PS2APP Alzheimer\u2019s mouse model. J Neurosci 40(9):1956\u20131974. https:\/\/doi.org\/10.1523\/JNEUROSCI.1871-19.2019","journal-title":"J Neurosci"},{"issue":"6","key":"5925_CR36","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s41593-024-01620-8","volume":"27","author":"N Rachmian","year":"2024","unstructured":"Rachmian N, Medina S, Cherqui U, Akiva H, Deitch D, Edilbi D, Croese T, Salame TM et al (2024) Identification of senescent, TREM2-expressing microglia in aging and Alzheimer\u2019s disease model mouse brain. Nat Neurosci 27(6):1116\u20131124. https:\/\/doi.org\/10.1038\/s41593-024-01620-8","journal-title":"Nat Neurosci"},{"issue":"3","key":"5925_CR37","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1523\/JNEUROSCI.2110-16.2016","volume":"37","author":"TR Jay","year":"2017","unstructured":"Jay TR, Hirsch AM, Broihier ML, Miller CM, Neilson LE, Ransohoff RM, Lamb BT, Landreth GE (2017) Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer\u2019s disease. J Soc Neurosci 37(3):637\u2013647. https:\/\/doi.org\/10.1523\/JNEUROSCI.2110-16.2016","journal-title":"J Soc Neurosci"},{"issue":"5","key":"5925_CR38","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s11064-019-02748-x","volume":"44","author":"J Zhou","year":"2019","unstructured":"Zhou J, Yu W, Zhang M, Tian X, Li Y, L\u00fc Y (2019) Imbalance of microglial TLR4\/TREM2 in LPS-treated APP\/PS1 transgenic mice: a potential link between Alzheimer\u2019s disease and systemic inflammation. Neurochem Res 44(5):1138\u20131151. https:\/\/doi.org\/10.1007\/s11064-019-02748-x","journal-title":"Neurochem Res"},{"key":"5925_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13148-016-0202-9","volume":"8","author":"N Celarain","year":"2016","unstructured":"Celarain N, S\u00e1nchez-Ruiz de Gordoa J, Zelaya MV, Rold\u00e1n M, Larumbe R, Pulido L, Echavarri C, Mendioroz M (2016) TREM2 upregulation correlates with 5-hydroxymethycytosine enrichment in Alzheimer\u2019s disease hippocampus. Clin Epigenetics 8:37. https:\/\/doi.org\/10.1186\/s13148-016-0202-9","journal-title":"Clin Epigenetics"},{"key":"5925_CR40","doi-asserted-by":"publisher","unstructured":"Cruchaga C, Kauwe JS, Harari O, Jin SC, Cai Y, Karch CM, Benitez BA, Jeng AT et al (2013) GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer\u2019s disease. Neuron 78(2):256\u2013268. https:\/\/doi.org\/10.1016\/j.neuron.2013.02.026","DOI":"10.1016\/j.neuron.2013.02.026"},{"issue":"12","key":"5925_CR41","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.3390\/cells12121597","volume":"12","author":"A Lee-Gosselin","year":"2023","unstructured":"Lee-Gosselin A, Jury-Garfe N, You Y, Dabin L, Soni D, Dutta S, Rochet JC, Kim J et al (2023) TREM2-deficient microglia attenuate tau spreading in vivo. Cells 12(12):1597. https:\/\/doi.org\/10.3390\/cells12121597","journal-title":"Cells"},{"issue":"43","key":"5925_CR42","doi-asserted-by":"publisher","first-page":"11524","DOI":"10.1073\/pnas.1710311114","volume":"114","author":"CEG Leyns","year":"2017","unstructured":"Leyns CEG, Ulrich JD, Finn MB, Stewart FR, Koscal LJ, Remolina Serrano J, Robinson GO, Anderson E et al (2017) TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy. Proc Natl Acad Sci USA 114(43):11524\u201311529. https:\/\/doi.org\/10.1073\/pnas.1710311114","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"5925_CR43","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1038\/s41467-022-29552-6","volume":"13","author":"C Wang","year":"2022","unstructured":"Wang C, Fan L, Khawaja RR, Liu B, Zhan L, Kodama L, Chin M, Li Y et al (2022) Microglial NF-\u03baB drives tau spreading and toxicity in a mouse model of tauopathy. Nat Commun 13(1):1969. https:\/\/doi.org\/10.1038\/s41467-022-29552-6","journal-title":"Nat Commun"},{"issue":"40","key":"5925_CR44","doi-asserted-by":"publisher","first-page":"10172","DOI":"10.1073\/pnas.1811411115","volume":"115","author":"FA Sayed","year":"2018","unstructured":"Sayed FA, Telpoukhovskaia M, Kodama L, Li Y, Zhou Y, Le D, Hauduc A, Ludwig C et al (2018) Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy. Proc Natl Acad Sci U S A 115(40):10172\u201310177. https:\/\/doi.org\/10.1073\/pnas.1811411115","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5925_CR45","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221850","volume":"220","author":"G Carling","year":"2023","unstructured":"Carling G, Luo W, Gan L (2023) Friend turned foe: TREM2 agonist in battles against tau. J Exp Med 220(1):e20221850. https:\/\/doi.org\/10.1084\/jem.20221850","journal-title":"J Exp Med"},{"key":"5925_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2021.111438","volume":"195","author":"Q Qin","year":"2021","unstructured":"Qin Q, Teng Z, Liu C, Li Q, Yin Y, Tang Y (2021) TREM2, microglia, and Alzheimer\u2019s disease. Mech Ageing Dev 195:111438. https:\/\/doi.org\/10.1016\/j.mad.2021.111438","journal-title":"Mech Ageing Dev"},{"key":"5925_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105630","volume":"165","author":"F Filipello","year":"2022","unstructured":"Filipello F, Goldsbury C, You SF, Locca A, Karch CM, Piccio L (2022) Soluble TREM2: innocent bystander or active player in neurological diseases? Neurobiol Dis 165:105630. https:\/\/doi.org\/10.1016\/j.nbd.2022.105630","journal-title":"Neurobiol Dis"},{"issue":"1","key":"5925_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-66211-w","volume":"14","author":"F Nabizadeh","year":"2024","unstructured":"Nabizadeh F, Seyedmirzaei H, Karami S (2024) Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer\u2019s disease: a longitudinal study. Sci Rep 14(1):15318. https:\/\/doi.org\/10.1038\/s41598-024-66211-w","journal-title":"Sci Rep"},{"issue":"24","key":"5925_CR49","doi-asserted-by":"publisher","DOI":"10.1172\/JCI158708","volume":"132","author":"A Zhao","year":"2022","unstructured":"Zhao A, Jiao Y, Ye G, Kang W, Tan L, Li Y, Deng Y, Liu J et al (2022) Soluble TREM2 levels associate with conversion from mild cognitive impairment to Alzheimer\u2019s disease. J Clin Invest 132(24):e158708. https:\/\/doi.org\/10.1172\/JCI158708","journal-title":"J Clin Invest"},{"issue":"1","key":"5925_CR50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40035-025-00515-3","volume":"14","author":"X Qi","year":"2025","unstructured":"Qi X, Zhu K, Ke W, Wang J, Mao S, Chen G (2025) Roles of TREM2 in Alzheimer\u2019s disease. Transl Neurodegener 14(1):55. https:\/\/doi.org\/10.1186\/s40035-025-00515-3","journal-title":"Transl Neurodegener"},{"issue":"1","key":"5925_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09118-9","volume":"10","author":"L Zhong","year":"2019","unstructured":"Zhong L, Xu Y, Zhuo R, Wang T, Wang K, Huang R, Wang D, Gao Y et al (2019) Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer\u2019s disease model. Nat Commun 10(1):1365. https:\/\/doi.org\/10.1038\/s41467-019-09118-9","journal-title":"Nat Commun"},{"issue":"1","key":"5925_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42505-x","volume":"14","author":"X Zhang","year":"2023","unstructured":"Zhang X, Tang L, Yang J, Meng L, Chen J, Zhou L, Wang J, Xiong M et al (2023) Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer\u2019s disease. Nat Commun 14(1):6670. https:\/\/doi.org\/10.1038\/s41467-023-42505-x","journal-title":"Nat Commun"},{"issue":"3","key":"5925_CR53","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20160844","volume":"214","author":"L Zhong","year":"2017","unstructured":"Zhong L, Chen XF, Wang T, Wang Z, Liao C, Wang Z, Huang R, Wang D et al (2017) Soluble TREM2 induces inflammatory responses and enhances microglial survival. J Exp Med 214(3):597\u2013607. https:\/\/doi.org\/10.1084\/jem.20160844","journal-title":"J Exp Med"},{"key":"5925_CR54","doi-asserted-by":"publisher","unstructured":"Mummery CJ, Mayorga AJ, Simmons A, Chow TW, Burgess B, Nguyen T, Gao J, Budda B et al (2026) The TREM2 agonistic antibody AL002 in early Alzheimer\u2019s disease: a phase 2 randomized trial. Nat Med. https:\/\/doi.org\/10.1038\/s41591-026-04273-1. Advance online publication.","DOI":"10.1038\/s41591-026-04273-1"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05925-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05925-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05925-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:58:56Z","timestamp":1780437536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05925-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5925"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05925-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"668"}}